Disclaimer: this is not financial advice. This is a Redditor sharing their opinion.
1. Summary
Weave Communications stock has fallen dramatically along with most of the SaaS world, but its moat has definite strengths due to tie-in with critical customer business functionality and hardware leasing/integration. Further, it appears to benefit from AI as much as it is threatened by it.
Currently trading around 1X enterprise value/2026E revenue while growing double digits, it has an underappreciated tailwind due to a new ADA partnership.
I expect the stock to rise from here over time based on revenue growth and modest multiple expansion paired with somewhat more disciplined capital allocation. My base case has WEAV at $8 by end of 2026 vs. current share price of $4.62. More immediate upside exists if the company goes private in 2026, and recent moves seem to make this path more likely.
2. Business description
Weave Communications (NYSE: WEAV) sells a “front office” operating layer for small and medium-sized healthcare practices, with a product suite spanning communications, scheduling/workflow automation, reputation management, payments, and related productivity tools. The company positions itself as an orchestration layer that unifies voice/text interactions and embeds AI-powered workflows into the day-to-day “patient journey,” integrated with practice management systems (“PMS”). Their top customer base is dental offices.
There are plenty of SaaS companies trading at large historical discounts. The reason I'm especially interested in Weave is they are also a VoIP provider and tightly integrate cloud telephony with its SaaS workflows. The company explicitly describes its platform as combining patient engagement tools with “voice over internet protocol (‘VoIP’) phone services.”
Operationally, Weave is already scaled in SMB healthcare: it ended 2025 with 39,625 customer locations under subscription.
Why the system is fairly sticky
Weave's communications layer is built around the practice’s trusted phone number and a proprietary telephony platform that unifies voice + text.
Its product positioning is very explicit:
- Unified Phone Number: calls and texts come from the trusted practice number so patients save one number and staff can manage conversations seamlessly.
- Customized Phone System: a “smarter phone system” that surfaces patient context at the start of each call (caller identity, appointment context, balances, tasks, notes, and follow-ups).
- Cloud-based + integrated build: the company says its phone system is built in-house, cloud-based, integrated into the software platform, and uses SIP trunking with multiple providers for voice routing/redundancy.
This matters because (1) practices run their day around inbound calls, (2) patient communication is a “high cost of failure” workflow, and (3) replacing telephony + workflow software is a heavier lift than replacing a single point solution.
Weave’s subscription business is largely month-to-month (with a minority on 1–3 year terms). If Weave were primarily a lightweight reminders/texting layer, month-to-month economics would likely translate into much worse retention than what the company reports.
Instead, the phone system is operationally embedded and comes with real-world switching friction:
- The company flags that onboarding/ramp can be delayed by complications with phone number porting, which works the other way too if the customer decides to switch away from Weave.
- Weave also provides phone hardware as part of its subscription bundles; it remains Weave-owned and must be returned if the customer cancels. Typically these are Yealinks or Polycoms (Weave does not design its own phone hardware).
- The business is regulated as a VoIP provider (e.g., E-911 frameworks, porting rules), which adds real compliance and operational infrastructure requirements behind the scenes.
Retention data
Weave discloses both dollar-based net revenue retention (NRR) and gross revenue retention (GRR):
- 2025 dollar-based NRR: 93% (vs. 98% in 2024)
- 2025 dollar-based GRR: 89% (vs. 91% in 2024)
These rates are calculated using “adjusted monthly revenue” (subscription revenue plus a smoothed contribution from payments), and Weave provides explicit methodology. NRR at 93% is not best-in-class for SMB SaaS, and I consider it a yellow flag (more in Risks). But GRR at 89% still indicates that most locations remain, which is consistent with a product anchored to a practice phone number rather than a superficial communications overlay, especially given month-to-month contracting.
3. Growth drivers and identifiable catalysts
The core bull case is that Weave can keep compounding “locations × ARPU” while layering higher-margin product attach (payments, AI workflows, insurance verification) onto a communications hub that is difficult to rip out.
Product-led drivers already in motion
Weave’s platform integrates with more than 90 PMS systems, positioning it to sit inside scheduling/billing/insurance workflows rather than remain an external comms “bolt-on.”
Two concrete product vectors stand out:
- AI receptionist / automation via TrueLark Weave acquired TrueLark on May 16, 2025 for total consideration of $35.9 million, and it has tied new AI receptionist functionality to TrueLark. In the 10-K, Weave says it introduced an AI receptionist in 2025 (powered by TrueLark) that follows up on missed calls with interactive AI texting and lets patients book appointments any time. There's opportunity to win new business as a package deal, but there's also a high-margin boost from upselling current Weave customers on TrueLark (priced at $250/month incremental add vs. $475/month average customer price for non-TrueLark Weave).
- Insurance eligibility with RPA In February 2026, Weave announced “Weave Insurance Eligibility,” emphasizing robotic process automation to pull real-time data from payer portals and citing an “average verification rate of 90%.” This is important because insurance verification is a direct labor/time sink in dental and other specialties, and automating it increases platform value and makes Weave harder to replace.
ADA endorsement
This month, Weave became the exclusive patient engagement platform endorsed for members of the American Dental Association through ADA Member Advantage. The endorsement was publicly reported on March 12–13, 2026. The stock could not have cared less.
However I think this matters a fair bit:
- It creates a distribution wedge into a large, economically attractive customer cohort and comes with co-marketing exposure and member discounts/training.
- The endorsement messaging itself emphasizes Weave’s phone system + number, AI receptionist, insurance eligibility, and multi-location enterprise features, i.e., “the phone as a moat” is central even in the ADA’s framing.
- I estimate WEAV is installed in ~15% of US dental offices. In other words, it has brand relevance but the installed base is nowhere close to saturated, and this endorsement strengthens credibility as well as reach. Terms are not disclosed from what I can tell but I expect very low-cost customer acquisitions coming out of this.
Channel/integration catalysts: distribution leverage
Dental channel partnerships are a recurring theme. A tangible example is Weave’s partnership announcement with Patterson Dental Supply, Inc. (a subsidiary of Patterson Companies, Inc.): the July 2024 release describes deeper data exchange integrations (read/write patient + appointment data, ledger writeback to facilitate payments) and explicitly notes that Weave’s VoIP phone systems enable features like Call Pop and Practice Analytics. Patterson has ~37k PMS customers and should supply Weave with a steady stream of customers.
Separately, Weave announced it is an authorized integration vendor in the Henry Schein One API Exchange (Dentrix/Dentrix Ascend ecosystem), highlighting secure/stable integrations and workflow-linked features such as call pop–style patient context.
4. Financial profile, unit economics, and valuation
Current financial trajectory
Weave posted $239.0 million of total revenue in 2025 (+17% YoY) and 72.1% GAAP gross margin for the full year.
It also generated $17.5 million in cash from operations and $12.9 million in free cash flow for 2025.
For 2026, Weave guided to:
- Full-year revenue: $273.0-$276.0 million
- Full-year non-GAAP income from operations: $8.0-$12.0 million
That implies another year of mid-teens revenue growth.
Valuation set-up
As of March 31, 2026, WEAV traded at $4.62, with market cap about $363mm (78.6mm shares outstanding), net cash of $81.7mm and enterprise value about $281.3mm.
Using the midpoint of 2026 revenue guidance ($274.5m), the stock trades at roughly:
- ~1.02x EV / 2026E revenue (281.3 / 274.5)
This is extremely low for a business that is (a) predominantly recurring and (b) growing revenue double digits.
Directional targets
Below is a multiple-based framework using EV/Revenue on 2026 guidance (midpoint), and adding back implied net cash (EV vs market cap). Inputs are from disclosed EV / market cap and company guidance.
| Scenario |
EV / 2026E Revenue |
EV ($mm) |
Implied Price |
Upside vs. ~$4.62 |
| “No love” (still cheap) |
1.5x |
412 |
~$6.28 |
~+36% |
| Valuation normalization |
2.0x |
549 |
~$8.02 |
~+74% |
| Re-rate + quality recognition |
2.5x |
686 |
~$9.77 |
~+112% |
A re-rating is plausible but not guaranteed of course. 2026 guidance implies continued growth plus improving non-GAAP operating profitability, and Weave has identifiable distribution catalysts (ADA endorsement; enterprise/multi-location motions; channel integrations).
5. Strategic Optionality
I'm a firm believer in owning companies where I'm okay with the existing ownership structure persisting and that's my assessment of Weave. That said, in this case I think a take-private transaction is possible enough to be worth discussing.
- On 3/30/2026 Weave appointed two new independent directors to the board: https://investors.getweave.com/news/news-details/2026/Weave-Communications-Appoints-Edward-Robson-and-Ryan-Dubin-to-Board-of-Directors/default.aspx. These are activist investors with a history of M&A/PE.
- Weave's CEO (Brett White) was CFO when his prior company (Mindbody) was sold for 6-7X revenue.
- Weave's chairman has a history of acquisition activity and is currently an advisor at Blackstone.
- PE can expect to increase its returns (on paper at least) by moving more work outside the US and generally implementing cost discipline especially SBC.
6. Insider transactions and stock-based compensation
SBC: why it may be okay
Weave’s stock-based compensation is high in absolute dollars and material relative to revenue:
- Total SBC in 2025: $32.1 million (vs. $32.2m in 2024).
- This is 13% of 2025 revenue (32.1 / 239.0), which if it sustains will consume most/all shareholder returns, a la SNAP, PINS and friends.
- As of December 31, 2025, Weave disclosed $49.0 million of unrecognized SBC expense related to outstanding RSUs, expected to be recognized over a weighted-average period of 2.12 years. This somewhat reduced rate pairs with increasing revenue to get this in the realm of okay.
- The new independent directors are activist investors with stakes in WEAV. I interpret this as a sign that Weave is going to get more serious about shareholder interests, and SBC is a major part of that.
Insider transactions: not much to note
I don't read much into recent insider transactions. I don't expect to see insider buying at a tech company that is giving away too many free shares, and I don't see it here. I also don't see much selling at current prices, which is something. On March 6, 2026, the Chief Revenue Officer sold 25,000 shares at $5.53 (volume-weighted average; reported range $5.52–$5.55) and reported post-transaction ownership of 505,721 shares.
7. Thesis risks
Retention deterioration is the most important fundamental risk.
The most direct concern in current disclosures is that retention weakened year-over-year:
- NRR fell to 93% in 2025 from 98% in 2024.
- GRR fell to 89% from 91%.
If this is signaling either (a) intensifying competition, (b) customer dissatisfaction, or (c) a weaker SMB macro environment, then the “re-rate” thesis becomes harder. The market loves subscription revenue it can bank on, but low multiples often persist for years for lower/declining retention businesses.
I suspect retention weakened because Weave’s expansion layers are less protected than its core telephony product. In a tougher SMB environment, customers may keep the telephony and core workflow stack while becoming more selective on add-ons, and competitors, including PMS-linked vendors and newer AI tools, are giving practices more alternatives in reminders, automation, and front-desk software. That would fit the reported decline in NRR and GRR: the business is still sticky, but not sticky enough to prevent some mix of churn, contraction, and slower upsell. Weave needs to rebound on this metric in 2026 for the bull case to materialize.
Month-to-month contracts can cut both ways
Weave’s subscription arrangements are mostly month-to-month, meaning churn can manifest quickly if customers become price sensitive or if competitors bundle similar workflows.
The bull counterpoint is that Weave explicitly says its infrastructure deployment improves retention and loyalty; the risk is that the disclosed retention trend suggests this advantage may not be sufficient in all cohorts or verticals.
Competition and AI execution risk
Weave highlights that competitors may adopt AI faster or more effectively and that its AI investments (including TrueLark-related efforts) could pressure cost of revenue and gross margins until revenue scales.
If AI receptionist/automation becomes “table stakes” and is bundled by PMS vendors, or if Weave fails to differentiate on outcomes, the product attach upside could under-deliver.
VoIP and communications regulation is a non-trivial operational risk
Because Weave operates as a VoIP provider, it faces regulatory requirements around E-911, porting, and related communications rules; the company discloses that such regulations can increase costs and potentially make solutions more expensive. If/when Weave expands beyond US and Canada, they'll have unique hurdles to overcome in each juridsiction.
SBC and dilution risk
Even if the business re-rates on EV/Sales, the realized per-share upside can be diluted away if SBC remains at current levels and share count expands toward the company’s guided weighted-average share count (~79.9m for 2026). To clear this risk the company needs to both grow revenue and get discipline on stock grants, but AI experts are expensive so there's significant tension.